Drobnjak, Marija External Entity

Publications

Sort by

Selected publications

  • Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer.  Clinical cancer research : an official journal of the American Association for Cancer Research2002 Academic Article GET IT
    Times cited: 167

Other